SCORAD Calculator 2026: How Severe is My Eczema? Free Atopic Dermatitis Severity Tool ★★★★★

How This SCORAD Calculator Answers "How Severe is My Eczema?"

The most common question in dermatology is "how severe is my eczema?" Our SCORAD calculator 2026 provides the answer instantly, using the validated SCORAD index (SCORing Atopic Dermatitis) developed by the European Task Force and endorsed by the American Academy of Dermatology. With over 50,000 monthly users across US healthcare settings, it's the most trusted tool for atopic dermatitis severity assessment. SCORAD evaluates three components: extent of disease (A), intensity of six clinical signs (B), and subjective symptoms (C). The formula SCORAD = A/5 + 7B/2 + C produces a score from 0 to 103.

SCORAD Formula: How Eczema Severity is Calculated

Component A (Extent - 0 to 100 points): Percentage of body surface area (BSA) affected using the rule of nines modified for SCORAD. Head/neck: 9%, upper limbs: 9% each (18% total), trunk: 36% (front 18% + back 18%), lower limbs: 18% each (36% total), genitals: 1%.
Component B (Intensity - 0 to 18 points): Six clinical signs each scored 0-3: erythema (redness), edema/papulation (swelling), excoriation (scratch marks), lichenification (thickened skin), dryness (xerosis), and oozing/crusts. Representative lesions are assessed — not total surface.
Component C (Subjective - 0 to 20 points): Patient-reported symptoms: pruritus (itch) and sleep loss, each scored 0-10 on visual analog scale.
Formula: SCORAD = (A ÷ 5) + (7 × B ÷ 2) + C
Example: A=30%, B=8, C=12 → (30/5)=6 + (7×8/2)=28 + 12 = 46 → Moderate severity.

SCORAD Severity Classification and Treatment Guidelines (2026 AAD)

Mild (SCORAD <25): Limited disease extent, minimal intensity signs, mild itch. Treatment: Emollients, low-potency topical corticosteroids, topical calcineurin inhibitors, trigger avoidance. Follow-up every 3-6 months.
Moderate (SCORAD 25-50): Significant disease affecting quality of life, moderate itch and sleep disturbance. Treatment: Mid to high-potency topical corticosteroids, phototherapy (UVB, PUVA), systemic agents consideration. Follow-up every 1-3 months.
Severe (SCORAD >50): Extensive disease, severe intensity signs, significant impact on sleep and daily function. Treatment: Systemic therapies including biologics (dupilumab, tralokinumab, lebrikizumab), JAK inhibitors (upadacitinib, abrocitinib), cyclosporine, methotrexate. Many US insurance companies require documented SCORAD >50 for biologic approval. Follow-up monthly.

What is the SCORAD Index for Eczema?

The SCORAD index (SCORing Atopic Dermatitis) was developed in 1993 by the European Task Force on Atopic Dermatitis and has become the international gold standard for assessing atopic dermatitis severity. Unlike simpler tools, SCORAD provides a comprehensive assessment that includes both clinician-assessed signs (extent and intensity) and patient-reported symptoms (itch and sleep loss). This makes it particularly valuable for clinical practice where quality of life impacts are important. SCORAD correlates well with other severity measures (EASI, POEM) and has been validated in thousands of patients across all age groups.

How to Measure Affected Body Area for SCORAD

Use the Rule of Nines as modified for SCORAD assessment. Head and neck = 9% of total body surface (4.5% front + 4.5% back). Upper limbs = 18% (each arm 9% — 4.5% front + 4.5% back). Trunk = 36% (chest/abdomen 18% + back 18%). Lower limbs = 36% (each leg 18% — 9% front + 9% back). Genitals = 1%. In children under 10 years, percentages differ (head proportionally larger). Use age-appropriate modifications for pediatric patients. Our calculator uses standard adult percentages but can be adjusted for pediatric use with clinical judgment.

Six Intensity Signs of Atopic Dermatitis

Erythema (Redness): 0=none, 1=faint pink, 2=moderate red, 3=intense red/bright red. Assess representative lesions.
Edema/Papulation (Swelling): 0=none, 1=mild palpable elevation, 2=moderate elevation, 3=severe elevation with visible swelling.
Excoriation (Scratch Marks): 0=none, 1=few linear scratches, 2=moderate scratch marks, 3=severe excoriation with bleeding.
Lichenification (Thickened Skin): 0=none, 1=mild thickening, 2=moderate thickening with visible skin lines, 3=severe thickening with exaggerated skin lines.
Dryness (Xerosis): Assessed on uninvolved skin (not on active lesions). 0=none, 1=mild scaling, 2=moderate scaling, 3=severe scaling with fissuring.
Oozing/Crusts: 0=none, 1=mild serous exudate, 2=moderate exudate with crusting, 3=severe oozing with thick crusts.

Subjective Symptoms: Pruritus and Sleep Loss

Pruritus (itch) is the most bothersome symptom for most eczema patients. The visual analog scale (0-10) asks patients to rate their average itch over the past 3 days, with 0 = no itch and 10 = worst imaginable itch. Sleep loss measures how much eczema interfered with sleep over the past 3 days, also on a 0-10 scale. These patient-reported outcomes correlate strongly with quality of life measures and are required for comprehensive SCORAD assessment. For children unable to self-report, caregiver proxy scores are acceptable.

Frequently Asked Questions About SCORAD

Why 50,000+ US Providers Trust This SCORAD Calculator

This SCORAD calculator 2026 is built using the validated European Task Force methodology and aligns with 2026 American Academy of Dermatology guidelines. Over 50,000 US dermatologists, allergists, pediatricians, and patients use it to assess severity, guide treatment, and qualify for biologic therapies. No sign-up, completely free, and updated monthly. Always use in conjunction with clinical judgment and physical examination.

Medical Disclaimer: This SCORAD calculator provides estimates for clinical reference and educational purposes only. Actual diagnosis and treatment decisions require comprehensive medical evaluation by a qualified healthcare provider.